BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma & Biopharma Manufacturing

IDT Biologika Ramps Up Global CDMO Expansion Following SK Bioscience Acquisition

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that IDT Biologika, a...

May 21, 2025 | News

Pfizer Strikes $1.25B Ex-China Licensing Deal With China’s 3SBio for Cancer Antibody SSGJ-707

Pfizer Inc. announced it has entered into an exclusive global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK), a leading Chinese biopharmaceutic...

May 20, 2025 | News

WuXi Biologics to Divest Leverkusen Plant to Terumo for €150M, Refocuses on Global DP Expansion

WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has entered into ...

May 15, 2025 | News

Sanyou Biopharmaceuticals and TransRecoBio Form Strategic Alliance to Accelerate Innovative Formulation Development

Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Biopharmaceuticals") and TransRecoBio (Wenzhou) Biotechnology Co., Ltd. ("TransRecoBio") officially...

May 14, 2025 | News

Rockwell Automation Launches FactoryTalk PharmaSuite® 12.00 to Modernize MES for Regulated Pharma and Biopharma Manufacturing

Rockwell Automation, Inc. , the world's largest company dedicated to industrial automation and digital transformation, announced the launch of Fa...

May 14, 2025 | News

Novo Holdings Makes First Pharmaceutical Manufacturing Investment in India with Stake in SCHOTT Poonawalla

Novo Holdings, a global life sciences investor, announced its investment in SCHOTT Poonawalla, India's leading provider of high-quality drug containment an...

May 14, 2025 | News

Roche and Genentech Invest $700M in First U.S. East Coast Facility to Advance Obesity Drug Manufacturing

Future 700,000 sq. ft. facility in Holly Springs, NC, will support pharma division’s metabolic medicines portfolio $700+ million investm...

May 13, 2025 | News

Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...

May 08, 2025 | News

Genezen to Manufacture Lentiviral Vector for Optieum’s CAR-T Therapy Targeting Glioblastoma

Genezen, a leading viral vector Contract Development and Manufacturing Organization (CDMO), and Optieum Biotechnologies, Inc. (Optieum), a preclinical stag...

May 06, 2025 | News

Robinson Pharma Expands Production with 10 New Softgel Machines, Boosting Capacity and Speed Across Supplement Formats

Robinson Pharma, a global leader in nutraceutical contract manufacturing, has announced a major expansion of its manufacturing capabilities. As part of thi...

May 02, 2025 | News

Asimov and Cytiva Unite to Fast-Track Complex Biologics Production

Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell line development and c...

April 30, 2025 | News

Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion

Amgen (NASDAQ: AMGN), a global leader in biotechnology, announced a $900 million expansion of its state-of-the-art biomanufacturing facility in New A...

April 29, 2025 | News

Australia’s Viral Vector Manufacturing Facility Selects SYSPRO Cloud ERP to Drive Quality and Compliance in Biopharma Manufacturing

Viral Vector Manufacturing Facility Pty Ltd (VVMF) has selected SYSPRO for its Cloud ERP system. VVMF is Australia’s first viral...

April 29, 2025 | News

Merck to Acquire SpringWorks Therapeutics for $3.9 Billion, Strengthening Rare Tumor Leadership

Purchase price of $47 per share in cash represents an enterprise value of €3.0 billion ($3.4 billion), or an equity value of approximately $3.9 bill...

April 28, 2025 | News

Stay Connected